"Elevate is thrilled to see Kristin take on this new role with Heartland Bioworks," said Christopher “Toph” Day, CEO of Elevate Ventures. "Her leadership and vision will be invaluable in driving continued growth and innovation within the life sciences sector. We look forward to our continued partnership and collaboration to support Indiana's entrepreneurial ecosystem."
Eilenberg's appointment comes at a pivotal time for Heartland Bioworks, as the organization looks to implement the recently-announced $51 million implementation funding from the U.S. Economic Development Administration. Under her guidance, Heartland Bioworks will focus on expanding its programming, enhancing its member services, and strengthening its partnerships with key stakeholders, including academic institutions, healthcare providers, and industry leaders.
"I am honored and excited to take on this role at Heartland Bioworks," said Eilenberg. "Indiana's life sciences space is brimming with talent and innovation, and I am committed to leveraging Heartland Bioworks' unique position to unleash the full potential of our region's entrepreneurial spirit. Together with our members, partners, and the broader community, we will continue to drive groundbreaking discoveries and solutions that improve lives."
Kristin Eilenberg will officially assume the role of Heartland Bioworks' Executive Director on November 6, 2024.
About Heartland Bioworks
Heartland Bioworks is an Indiana-based regional technology hub that seeks to advance Indiana’s biomanufacturing assets for the benefit of the state and the nation. Designated as Regional Technology and Innovation Hub (“Tech Hub”) in 2022, Heartland Bioworks will harness regional assets in life sciences and biomanufacturing to advance talent development in the life sciences and support scale-up bioinnovators, all with an eye towards enhancing national biosecurity and regional economic prosperity.
About Elevate Ventures
Elevate Ventures empowers entrepreneurs through investment and collaboration. Elevate is the #1 most active early stage VC in the Great Lakes Region and top 10 in the United States. We invest in high-potential, cross-sector innovative companies with a minimum $500M total addressable market (TAM) at the pre-seed, seed, and Series A stages. To learn more about Elevate Ventures, visit https://elevateventures.com.
###
Media Contact:
Amy Ross
Director of Communications, ARI
Amy.ross@theari.us
262-909-9056